CHM — Chimeric Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$8.46m
- AU$7.69m
- AU$3.97m
Annual cashflow statement for Chimeric Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | — | -0.003 | 3.53 | 12.9 | 8.19 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.84 | -13.2 | -16.3 | -7.54 | -7.28 |
| Capital Expenditures | -5.31 | -0.538 | -0.112 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.003 | -0.04 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.3 | -0.578 | -0.112 | — | — |
| Financing Cash Flow Items | -2.72 | -1.31 | -0.099 | -1.21 | 1.84 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 36.5 | 9.54 | 0.253 | 8.26 | 10 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 22.4 | -4.03 | -16 | 0.69 | 2.7 |